Search Results 1721-1730 of 17000 for monoclonal antibody

1. Pneumococcal 15-valent conjugate vaccine (intramuscular route) - Side effects & uses - Mayo Clinic

   It works by causing your body to produce its own protection (antibodies) against the disease. Pneumococcal infection can cause serious problems, such as ...

2. A Phase III, Prospective, Multicenter, Randomized, Controlled Clinical Trial to Demonstrate the Efficacy and Safety of Liposomal Cyclosporine A (L-CsA) Inhalation Solution Delivered via the PARI Investigational eFlow® Device plus Standard of Care versus Standard of Care Alone in the Treatment of Chronic Lung Allograft Syndrome / Bronchiolitis Obliterans Syndrome in Patients post Double Lung Transplantation (BOSTON-2) - Mayo Clinic

   Protocol Specific Definition ), etc. 2. Patients with acute antibody-mediated rejection at Screening. ... donor specific antibodies (DSA) at the Screening Visit ...

3. A Study of Nulojix® (Belatacept) as Maintenance Immunosuppression in Kidney Transplant Recipients - Mayo Clinic

   Recipients with Epstein-Barr virus (EBV) serostatus negative or unknown · History of acute rejection within 3 months prior to enrollment · History of antibody ...

4. Meningococcal vaccine and haemophilus b vaccine (intramuscular route) - Side effects & uses - Mayo Clinic

   The vaccine works by causing your body to produce its own protection (antibodies) against the disease. The following information applies only to the ...

5. Meningococcal vaccine (intramuscular route, subcutaneous route) - Side effects & uses - Mayo Clinic

   The vaccine works by causing your body to produce its own protection (antibodies) against the disease. Bexsero® and Trumenba® is active against group B ...

6. Meningococcal polysaccharide vaccine, diphtheria conjugate (intramuscular route) - Side effects & uses - Mayo Clinic

   The vaccine works by causing your body to produce its own protection (antibodies) against the bacteria. The following information applies only to the ...

7. Selinexor, Carfilzomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   Subject has plasma cell leukemia or Waldenstrom's macroglobuleinemia or POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal protein, and ...

8. Broad Evidence of Systemic Immune Activation in Long Term Survivors of Advanced Ovarian Cancer - Mayo Clinic

   ... antibody responses to folate receptor alpha and will have broad evidence of systemic immune activation. Participation eligibility. Participant eligibility ...

9. A Trial to Find and Investigate a Safe Dose of BI 836858 in Combination With Decitabine for Patients With Acute Myeloid Leukemia (AML) - Mayo Clinic

   Prior treatment with Cluster of differentiation 33 (CD33) antibody Further exclusion criteria apply. Participating Mayo Clinic locations. Study statuses ...

10. Targeting Matrix Metalloproteinases Using Tissue Inhibitors - Proteases in Cancer Laboratory - Mayo Clinic Research

    We're exploring the idea that TIMPs , like antibodies, can be engineered as targeted protein therapeutics of remarkable affinity and exquisite selectivity.